Gallic acid-d2
Based on 1 Customer Validation
Gallic acid-d2 is the deuterium labeled Gallic acid. Gallic acid (3,4,5-Trihydroxybenzoic acid) is a natural polyhydroxyphenolic compound and an free radical scavenger to inhibit cyclooxygenase-2 (COX-2). Gallic acid has various activities, such as antimicrobial, antioxidant, antimicrobial, anti-inflammatory, and anticance activities.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 99.59%
- CAS 番号: 294660-92-7
- 分子式: C7H4D2O5
- 分子量:172.13
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
-
HY-N1428S1
Citric acid-13C6Stable Isotope -
HY-N0666S8
L-Aspartic acid-d3Stable Isotope -
HY-19759
SRT 2183SIRT1 Activator -
HY-N6947
LuteinAnti-inflammatory Agent -
HY-B0373S1
Tiopronin-d3Stable Isotope -
HY-113327
1,3,7-Trimethyluric acidCaffeine Metabolite -
HY-66008
N-Acetyl mesalazine5-Aminosalicylic Acid Metabolite -
HY-N1446S
Oleic acid-13CStable Isotope -
HY-N0138S
Theobromine-d6Stable Isotope -
HY-B2167S
Docosahexaenoic acid-d5Stable Isotope -
HY-B0464S
Hydralazine-d4 hydrochlorideStable Isotope -
HY-100573S
Necrosulfonamide-d4Stable Isotope
Endogenous Metabolite アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
体外実験
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
アプリケーション
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
化学情報
-
CAS 番号 294660-92-7
-
非標識Cas 149-91-7
-
性状 Solid
-
分子量 172.13
-
分子式 C7H4D2O5
-
Color White to off-white
-
SMILES
OC(C1=C([2H])C(O)=C(C(O)=C1[2H])O)=O
-
別名
3,4,5-Trihydroxybenzoic acid-d2
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
純度とドキュメンテーション
-
データシート (272 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
[2]. Amaravani M, et al. COX-2 structural analysis and docking studies with gallic acid structural analogues. Springerplus. 2012 Dec;1(1):58. [Content Brief]
[3]. Bak EJ, et al. Gallic acid improves glucose tolerance and triglyceride concentration in diet-induced obesity mice. Scand J Clin Lab Invest. 2013 Dec73(8):607-14. [Content Brief]
[4]. Cheng Y, et al. Plant Natural Products Calycosin and Gallic Acid Synergistically Attenuate Neutrophil Infiltration and Subsequent Injury in Isoproterenol-Induced Myocardial Infarction: A Possible Role for Leukotriene B4 12-Hydroxydehydrogenase? Oxid Med Cell Longev. 20152015:434052. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Gallic acid-d2 関連分類
HY-N0523S 関連分類
Powered by Bioz